CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business Development David J. Haen will present at the 15th Annual BIO CEO & Investor Conference on Monday, February 11 at 1:30 p.m. Eastern time (10:30 a.m. Pacific time). The conference is being held at the Waldorf=Astoria Hotel in New York City.
